CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $56,000 | -76.8% | 14,928 | 0.0% | 0.00% | – |
| Q4 2015 | $241,000 | +53.5% | 14,928 | 0.0% | 0.00% | – |
| Q3 2015 | $157,000 | -72.2% | 14,928 | -33.3% | 0.00% | -100.0% |
| Q2 2015 | $564,000 | +171.2% | 22,392 | +200.0% | 0.00% | – |
| Q1 2015 | $208,000 | -75.4% | 7,464 | -83.9% | 0.00% | -100.0% |
| Q4 2014 | $844,000 | +770.1% | 46,423 | +522.0% | 0.00% | – |
| Q3 2014 | $97,000 | -65.6% | 7,464 | -65.2% | 0.00% | – |
| Q2 2014 | $282,000 | -42.1% | 21,450 | -35.7% | 0.00% | -100.0% |
| Q1 2014 | $487,000 | -90.8% | 33,359 | -83.7% | 0.00% | -90.0% |
| Q4 2013 | $5,299,000 | -7.6% | 204,238 | +26.2% | 0.01% | 0.0% |
| Q3 2013 | $5,736,000 | +60.3% | 161,893 | -29.4% | 0.01% | +42.9% |
| Q2 2013 | $3,578,000 | – | 229,182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 844,981 | $15,421,000 | 7.11% |
| DOHENY ASSET MANAGEMENT /CA | 195,345 | $3,565,000 | 1.70% |
| First Light Asset Management, LLC | 153,617 | $2,804,000 | 1.59% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,194,000 | 0.93% |
| Iguana Healthcare Management, LLC | 100,000 | $1,825,000 | 0.88% |
| Eventide Asset Management | 288,700 | $5,269,000 | 0.58% |
| Bedell Frazier Investment Counselling, LLC | 60,820 | $1,110,000 | 0.54% |
| STONERIDGE INVESTMENT PARTNERS LLC | 214,327 | $3,911,000 | 0.52% |
| Fernwood Investment Management, LLC | 31,350 | $572,000 | 0.49% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 168,560 | $3,076,000 | 0.37% |